Ingenza — a world-leading protein CRDMO — has entered a strategic relationship with Ab Biotechnology — a MHRA‑licensed GMP facilities provider — to support the development and GMP manufacturing of innovative biotechnology products.
In this instalment of our Inside Ingenza series, Jack Kay discusses our in-house AI/ML platform, codABLE™, and how it delivers unparalleled predictability and precision when tuning protein expression compared to traditional methods.
In this instalment of our Inside Ingenza series, Fraser Brown – Ingenza’s Head of Chemistry and Analytical Development – talks about a particularly complex protein we worked with.
This webinar highlights the opportunity for the exquisite selectivity of enzymatic biotransformations, conducted in vitro or in vivo, to overcome these challenges of tomorrow’s small molecule pharmaceutical manufacturing.
Thanks for joining us – if you would like to re-watch the webinar, the video has been made available below to watch again. Over the past two decades, the biopharma community has faced significant challenges in advancing exciting and potentially…
Thanks for joining us – if you would like to re-watch the webinar, the video has been made available below to watch again. Discover how Ingenza masters the production of complex proteins with viable, scalable and cost-effective bioprocesses. In this…